Amedeo's Top 20

Amedeo Smart

Independent Medical Education

14 November 2022

Multidisciplinary Journal Club

  1. Bloomfield FH, Jiang Y, Harding JE, Crowther CA, et al.
    Early Amino Acids in Extremely Preterm Infants and Neurodisability at 2 Years.
    N Engl J Med 2022;387:1661-1672.

  1. Weghuber D, Barrett T, Barrientos-Perez M, Gies I, et al.
    Once-Weekly Semaglutide in Adolescents with Obesity.
    N Engl J Med 2022.

  2. Moran MS, Ho AY.
    Radiation Therapy for Low-Risk Breast Cancer: Whole, Partial, or None?
    J Clin Oncol 2022.

  3. Falchi L, Vardhana SA, Salles GA.
    Bispecific antibodies for the treatment of B-cell lymphoma: Promises, unknowns and opportunities.
    Blood 2022.

  4. Ahmad E, Lim S, Lamptey R, Webb DR, et al.
    Type 2 diabetes.
    Lancet 2022.

  1. Holland TL, Bayer AS, Fowler VG.
    Persistent Methicilin-Resistant Staphylococcus aureus Bacteremia: Resetting the Clock for Optimal Management.
    Clin Infect Dis 2022;75:1668-1674.

  2. Wu CH, Li CC, Hsu YH, Liang FW, et al.
    Comparisons between different anti-osteoporosis medications on postfracture mortality: A population-based study.
    J Clin Endocrinol Metab 2022.

  3. Vijenthira A, Kuruvilla J, Crump M, Jain M, et al.
    Cost-Effectiveness Analysis of Frontline Polatuzumab-Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone and/or Second-Line Chimeric Antigen Receptor T-Cell Therapy Versus Standard of Care for Treatment of Patients With Intermediate- t
    J Clin Oncol 2022.

  4. Martin WRW, Younce JR, Campbell MC, Racette BA, et al.
    Neocortical Lewy body pathology parallels Parkinson's dementia, but not always.
    Ann Neurol 2022.

  5. Hagman BT, Falk D, Litten R, Koob GF, et al.
    Defining Recovery From Alcohol Use Disorder: Development of an NIAAA Research Definition.
    Am J Psychiatry 2022;179:807-813.

  1. Lau WCY, Torre CO, Man KKC, Stewart HM, et al.
    Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation : A Multinational Population-Based Cohort Study.
    Ann Intern Med 2022.

  2. Ginsberg C, Miller LM, Ofsthun N, Dalrymple LS, et al.
    Differences in Phosphate and Parathyroid Hormone Concentrations over the Day among Patients on Hemodialysis.
    J Am Soc Nephrol 2022;33:2087-2093.

  3. Ullmann TM, Papaleontiou M, Sosa JA.
    Current Controversies in Low-Risk Differentiated Thyroid Cancer: Reducing Overtreatment in an Era of Overdiagnosis.
    J Clin Endocrinol Metab 2022.

  4. Johnson ML, Cho BC, Luft A, Alatorre-Alexander J, et al.
    Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study.
    J Clin Oncol 2022.

  5. Gail MH, Jatoi I.
    Tools for Contralateral Prophylactic Mastectomy Decision Making.
    J Clin Oncol 2022;40:3653-3659.

  1. Jelinek T, Bezdekova R, Zihala D, Sevcikova T, et al.
    More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma.
    J Clin Oncol 2022.

  2. Carson JL, Brittenham GM.
    How I Treat Anemia with Red Blood Cell Transfusion and Iron.
    Blood 2022.

  3. Paradkar MS, Devaleenal DB, Mvalo T, Arenivas A, et al.
    Randomized Clinical Trial of High Dose Rifampicin with or without Levofloxacin versus Standard of Care for Paediatric Tuberculous Meningitis: The TBM-KIDS Trial.
    Clin Infect Dis 2022.

  4. Ghahremani M, Wang M, Chen HY, Zetterberg H, et al.
    Plasma P-Tau181 and Neuropsychiatric Symptoms in Preclinical and Prodromal Alzheimer Disease.
    Neurology 2022.

  5. Rugo HS, Im SA, Cardoso F, Cortes J, et al.
    Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial.
    J Clin Oncol 2022.


more..

Privacy Policy